Laboratory issues in gene therapy and emicizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Laboratory issues in gene therapy and emicizumab

Published:2020-05-29 Issue:S3 Volume:27 Page:142-147
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Bowyer Annette E.¹^ORCID,Lowe Anna E.²,Tiefenbacher Stefan³

Affiliation:

1. Department of Coagulation Sheffield Haemophilia and Thrombosis Centre Sheffield UK

2. UK National External Quality Assurance Scheme (NEQAS) for Blood Coagulation Sheffield UK

3. Colorado Coagulation Laboratory Corporation of America^® Holdings Englewood CO USA

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.13976

Reference54 articles.

1. Emicizumab for the treatment of haemophilia A: a narrative review;Franchini M;Blood Transfus,2019

2. Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophilia

3. The coagulation laboratory monitoring of Afstyla single-chain FVIII concentrate

4. Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: a two-centre study

5. Measurement of extended half‐life recombinant factor IX products in clinical practice

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern aspects of hemophilia A diagnosis;Pediatric Hematology/Oncology and Immunopathology;2024-04-18

2. Effect of emicizumab-neutralizing antibodies on activated partial thromboplastin time–based clotting time test results in patients treated with emicizumab;Research and Practice in Thrombosis and Haemostasis;2023-11

3. Reclassifying hemophilia to include the definition of outcomes and phenotype as new targets;Journal of Thrombosis and Haemostasis;2023-07

4. From a bispecific monoclonal antibody to gene therapy: A new era in the treatment of hemophilia A;Biomedical Papers;2023-03-15

5. Expert opinion paper on the treatment of hemophilia A with emicizumab;Hematology;2023-01-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3